The next meeting of the Transparency Council will be held on Monday, January 13.
The agenda includes:
- Preparation of a position paper on the evaluation of the drug Ocrevus (ocrelizumabum) under drug program B.29. "Treatment of patients with multiple sclerosis (ICD-10: G35)".
- Preparation of an opinion on the draft...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
